Comprehensive medication guide to Quviviq including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
With insurance, eligible patients using the QUVIVIQ360 savings card may pay as little as $25 per month, though coverage varies and prior authorization is often required.
Estimated Cash Pricing
Quviviq typically costs between $550 and $680 for a 30-day supply without insurance.
Medfinder Findability Score
55/100
Summarize with AI
On this page
Quviviq (Daridorexant) is a prescription medication approved by the FDA for the treatment of insomnia in adults who have difficulty falling asleep and/or staying asleep. It belongs to a class of drugs called dual orexin receptor antagonists (DORAs). Quviviq is manufactured by Idorsia Pharmaceuticals and is available as an oral tablet in 25 mg and 50 mg strengths. It is taken once nightly, within 30 minutes of going to bed, with at least 7 hours remaining before your planned wake-up time.
Quviviq works by blocking the orexin receptors (OX1 and OX2) in the brain. Orexin is a neuropeptide that promotes wakefulness. By blocking these receptors, Quviviq reduces the brain's drive to stay awake, allowing a more natural transition into sleep. Unlike older sleep medications such as benzodiazepines or Z-drugs (like Ambien), Quviviq does not interact with GABA receptors, which may result in a different side effect profile and lower risk of dependence.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
25 mg oral tablet — tablet
50 mg oral tablet — tablet
Quviviq scores a 55 out of 100 on our findability scale, meaning it can be moderately difficult to locate in stock. As a newer brand-name medication manufactured by Idorsia Pharmaceuticals, not all pharmacies routinely stock it. Chain pharmacies may not carry Quviviq regularly, and you may need to call around or check with specialty pharmacies. While Quviviq is not listed on the FDA Drug Shortage Database, its limited availability at some locations means patients should plan ahead when filling prescriptions.
Quviviq can be prescribed by a range of healthcare providers, including sleep medicine specialists, psychiatrists, neurologists, primary care physicians, and internal medicine doctors. Telehealth consultations are also available for Quviviq prescriptions in many cases. If you are struggling with insomnia, your primary care doctor is often a good starting point, though they may refer you to a sleep specialist for further evaluation.
Yes, Quviviq is classified as a Schedule IV controlled substance by the DEA. This means it has a recognized medical use but carries some potential for abuse and dependence, though the risk is considered lower than Schedule II or III substances. As a controlled substance, Quviviq prescriptions may have refill limitations and require proper identification at the pharmacy.
Serious but less common side effects include complex sleep behaviors (such as sleepwalking or sleep-driving), sleep paralysis, hallucinations, temporary leg weakness, and worsening of depression or suicidal ideation. Contact your healthcare provider immediately if you experience any of these serious side effects.
Know what you need? Skip the search.
Belsomra (Suvorexant)
Another dual orexin receptor antagonist (DORA), approved in 2014. Available in 10 mg and 20 mg doses. Also a Schedule IV controlled substance with a longer half-life of approximately 12 hours.
Dayvigo (Lemborexant)
A DORA approved in 2019, available in 5 mg and 10 mg doses. Schedule IV with a half-life of 17–19 hours and more selectivity for the OX2 receptor.
Ambien (Zolpidem)
A Z-drug that works on GABA receptors. Available in immediate-release and extended-release formulations. Schedule IV with generics available at much lower cost.
Lunesta (Eszopiclone)
Another GABA receptor modulator available in 1 mg, 2 mg, and 3 mg doses. Schedule IV with generic options at lower cost.
Prefer Quviviq? We can find it.
Strong CYP3A4 inhibitors
moderate(Ketoconazole, Itraconazole, Clarithromycin, Ritonavir) — Contraindicated; these significantly increase Daridorexant levels in the body.
Moderate CYP3A4 inhibitors
moderate(Erythromycin, Diltiazem, Fluconazole, Verapamil) — Dose must be reduced to 25 mg maximum.
Strong CYP3A4 inducers
moderate(Rifampin, Carbamazepine, Phenytoin, St. John's Wort) — Avoid concomitant use as they reduce Quviviq's effectiveness.
Other CNS depressants
moderate(Benzodiazepines, Opioids, Alcohol) — Additive CNS depression; use with caution.
Food interaction
moderateTaking Quviviq with or soon after a high-fat meal can delay onset of action by approximately 1.3 hours.
Quviviq represents a newer approach to treating insomnia by targeting the orexin system rather than the GABA pathway used by older sleep medications. While it can be moderately difficult to find in stock and carries a higher price tag ($550–$680 per month without insurance), the QUVIVIQ360 savings program can significantly reduce costs for eligible commercially insured patients. No generic version is currently available, with patents extending through 2034. If you're having trouble locating Quviviq at your local pharmacy, Medfinder can help you search for pharmacies that have it in stock near you.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards